"instanceType","uuid:ID","name","id","description","text","label"
"Objective","417bdbb1-11dd-4317-a187-27cdc6bb11cf","OBJ1","Objective_1","Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).",""
"Objective","2f2b3707-3d35-4650-bb30-c0ce1bde8fec","OBJ2","Objective_2","Safety","To document the safety profile of the xanomeline TTS.",""
"Objective","0dae8a40-ab6b-416f-857f-c33f204a806d","OBJ3","Objective_3","Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.",""
